HPLC column NUCLEODUR ® C 18 Gravity, 1.8 µm, 50 mm, 3 mm
Order number: 33T8.1
Part number: AC100008401
£ 686.93*
*Prices plus VAT plus shipping costs£ 824.32*
*incl. VAT, plus shipping costsPrice Breakdown
1
6
24
Designed with efficiency in synthetic processes in mind, the Separation columns for HPLC category includes the HPLC column NUCLEODUR ® C 18 Gravity, 1.8 μm, 50 mm, 3 mm. This UHPLC column features a high density C 18 phase based on high purity NUCLEODUR ® silica gel, endcapped to suppress unwanted polar interactions between the silica surface and the sample. Its enhanced pH stability, LC/MS suitability, and superior base deactivation make it an ideal choice for method development and valuable for RP applications. With a particle size of 1.8 μm, this column offers excellent pressure stability up to 900 bar and temperature stability up to 60 °C. Recommended applications include compounds with ionizable functional groups such as basic pharmaceuticals and pestic
- Category: Separation columns for HPLC
- pH stability: 1,0-11,0
- Column shape: Analytical separation column
- Specific surface according to BET: 340 m²/g
- Surface chemistry: Base deactivated (BDS), High density octadecyl (C 18 , ODS) modification
- Interactions / retention mechanism: hydrophobic (van der Waals)
- Particle type: Fully porous particles (FPP)
- L x Ø internal (column): 50 x 3 mm
- Endcapped: yes
- Separation principle: Reversed phase (RP)
- Particle size: 1.8 µm
- Temperature stability: 60 ° C
- Phase: C 18 Gravity
- Pore size: 110 Å
- Pressure stability: 900 bar
- Recommended application(s): In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals
- Pore volume: 0.9 ml/g
- Column volume: 0.35 ml
- Eluent in column: Acetonitrile - Water
- Similar phases: NUCLEOSIL ® C 18 HD Xterra ® RP 18 / MS C 18 Luna ® C 18 (2) Gemini ® Synergi™ Max RP Zorbax ® Extend C 18 Inertsil ® ODS III Purospher ® Star RP-18 Hypersil™ BDS
- USP listing: L1
- Column type: UHPLC column
| Name | Value | |
|---|---|---|
| Phase | : | C 18 Gravity |
| Endcapped | : | yes |
| Pore size | : | 110 Å |
| Column type | : | UHPLC column |
| Pore volume | : | 0.9 ml/g |
| USP listing | : | L1 |
| Column shape | : | Analytical separation column |
| pH stability | : | 1,0-11,0 |
| Column volume | : | 0.35 ml |
| Particle size | : | 1.8 µm |
| Particle type | : | Fully porous particles (FPP) |
| Similar phases | : | NUCLEOSIL ® C 18 HD Xterra ® RP 18 / MS C 18 Luna ® C 18 (2) Gemini ® Synergi™ Max RP Zorbax ® Extend C 18 Inertsil ® ODS III Purospher ® Star RP-18 Hypersil™ BDS |
| Eluent in column | : | Acetonitrile - Water |
| Surface chemistry | : | Base deactivated (BDS), High density octadecyl (C 18 , ODS) modification |
| Pressure stability | : | 900 bar |
| Separation principle | : | Reversed phase (RP) |
| Temperature stability | : | 60 ° C |
| L x Ø internal (column) | : | 50 x 3 mm |
| Recommended application(s) | : | In general compounds with ionizable functional groups such as basic pharmaceuticals and pesticides Analgesics Antidepressants Applications for extreme pH values (1-11) Anti-inflammatory drugs Herbicides Ideal for method development Immunosuppressants Pharmaceutical products Phytopharmaceuticals |
| Specific surface according to BET | : | 340 m²/g |
| Interactions / retention mechanism | : | hydrophobic (van der Waals) |
